What Is Insider Trading Activity Like At Bristol-Myers Squibb Company (BMY)?

Henrietta Strickland
January 19, 2018

Jackson Grant Investment Advisers Inc. now owns 3,905 shares of the biopharmaceutical company's stock worth $218,000 after purchasing an additional 15 shares in the last quarter. (PM) reported its last quarterly earnings on 9/29/2017 where the firm reported its Actual EPS of $1.27/share against the analyst consensus estimate of $1.38/share. Fairfax Financial Holdings Ltd Can who had been investing in Us Bancorp Del for a number of months, seems to be less bullish one the $93.12 billion market cap company. The Stock now has a Weekly Volatility of 1.75% and Monthly Volatility of 1.54%. About 14.46 million contracts were traded on 16-Jan-18 compared to daily average volume of 5.37 million shares. Analysts on average have given a price target of $63.86 to Bristol-Myers Squibb Company stock. It has underperformed by 13.69% the S&P500. About 6.54M shares traded or 19.27% up from the average. Plante Moran Finance Advsr Ltd Liability Corp reported 2,620 shares. (NASDAQ:LPLA) shares were trading lower by -2.09 percent ($-1.28) at $59.91 a piece in Tuesday's session. About 278,776 shares traded. It has underperformed by 15.91% the S&P500.

Wcm Investment Management increased Icon Plc (ICLR) stake by 2.07% reported in 2017Q3 SEC filing. It also increased its holding in Dr Pepper Snapple Group Inc (NYSE:DPS) by 11,800 shares in the quarter, for a total of 387,400 shares, and has risen its stake in General Dynamics Corp (NYSE:GD).

Investors sentiment is 1.12 in 2017 Q3. Its down 0.14, from 0.98 in 2017Q2. It dived, as 112 investors sold GE shares while 818 reduced holdings. Finally, North Star Asset Management Inc. boosted its position in Bristol-Myers Squibb by 5.8% during the 1st quarter. Buckhead Cap Lc, Georgia-based fund reported 3,545 shares. Blume Cap Mgmt owns 2,005 shares for 0.07% of their portfolio.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 1st. Segment Wealth Management Ltd Liability Com holds 0.13% or 6,078 shares. Glg Limited Company reported 169,273 shares. The stock price value Change from Open was at -1.93% with a Gap of 0.35%. Cibc Asset has 0.03% invested in Monsanto Company (NYSE:MON). The company shows Gross Margin and Operating Margin of 63.8 percent and 39.4 percent respectively. 18,436 are held by Stone Run Limited Liability Corporation. Of Oklahoma reported 124,094 shares. Inc. now owns 45,793 shares of the biopharmaceutical company's stock worth $2,490,000 after buying an additional 532 shares during the period. Therefore 54% are positive. The firm has "Underperform" rating by BMO Capital Markets given on Friday, July 28. Piper Jaffray has "Hold" rating and $6000 target. The rating was upgraded by Jefferies to "Buy" on Monday, December 19. Cowen & Co maintained it with "Hold" rating and $6500 target in Monday, August 14 report.

Since January 1, 0001, it had 0 insider purchases, and 3 selling transactions for $7.43 million activity. $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) was sold by Lynch Thomas J. Jr. on Tuesday, December 12. The RSI was created by J. Welles Wilder who was striving to measure whether or not a stock was overbought or oversold. On Monday, October 9 the insider MIZELL STEVEN sold $1.38M.

Cullen Frost Bankers Inc increased Ishares Msci Emerging Mkts Etf (EEM) stake by 13,563 shares to 130,704 valued at $5.86 million in 2017Q3. It also reduced Flex Ltd (NASDAQ:FLEX) stake by 52,759 shares and now owns 216,182 shares.

Since September 6, 2017, it had 1 insider buy, and 2 sales for $646,385 activity. Samuels Theodore R. II bought $249,187 worth of stock.

Comparing the number of shares sold short over time is a method analysts often use to get a reading on investor sentiment. Its down 0.34, from 1.12 in 2017Q2. This nets out to an increase of 10.72 million shares and is a bullish sign for BMY.

The most recent non open market insider trade was completed by BANCROFT CHARLES A on 12/02/2017, and was a disposition of 2,882 shares with a final price of $62.47. Foster Dykema Cabot & Ma accumulated 10,595 shares or 0.12% of the stock. Smith Chas P And Pa Cpas owns 0.06% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 6,951 shares. 3 analysts say it's a Hold while 0 analysts provided their expert opinion as Sell. Gru One Trading Lp invested in 0.03% or 67,748 shares. Broderick Brian C owns 22,240 shares. UBS Group reaffirmed a "buy" rating and set a $72.00 price objective (up previously from $62.00) on shares of Bristol-Myers Squibb in a research note on Friday, October 6th. (NASDAQ:CASY). First Eagle Invest Mngmt Limited Liability accumulated 0.08% or 327,439 shares. Amp Capital Invsts accumulated 0.29% or 801,325 shares. Indexiq Advsr Ltd Liability Corp has 0% invested in Hess Corporation (NYSE:HES) for 1,124 shares. Penn Davis Mcfarland stated it has 135,899 shares. Nationwide Fund reported 1.23 million shares. Cubist Systematic Strategies Lc stated it has 42,316 shares or 0.2% of all its holdings. Therefore 41% are positive.

The 21 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 64.00, with a high estimate of 75.00 and a low estimate of 49.00. The rating was maintained by Robert W. Baird on Thursday, August 31 with "Buy". The stock has "Neutral" rating by Hilliard Lyons on Monday, May 23. The rating was upgraded by Berenberg to "Buy" on Friday, January 22. The firm has "Equal-Weight" rating given on Friday, August 5 by Morgan Stanley. Of those analysts, 7 rate stock as a Strong Buy, 8 rate it as Hold, and just no analyst rates it as a Moderate Sell. The firm earned "Outperform" rating on Friday, December 9 by Cowen & Co. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has "Hold" rating given on Thursday, July 14 by Jefferies. Jefferies has "Hold" rating and $34.0 target.

Other reports by Click Lancashire

Discuss This Article